Skip to content

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health
FDA Approves Pirtobrutinib Treatment
Health

FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

October 4, 2026 Evan Vega

The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.

HHS Expands Mental Health
Health

HHS Awards Nearly $250 Million to Expand Mental Health and Addiction Treatment Services

October 4, 2026 Evan Vega
Ebola Worker Evacuated Congo
Health

Doctors Without Borders Worker Evacuated After Contracting Ebola in Democratic Republic of Congo Outbreak

October 3, 2026 Evan Vega
FDA authorizes screwworm drugs
Health

FDA issues emergency use authorization for drugs to prevent and treat New World screwworm in dogs and cats

September 16, 2026 Evan Vega
FDA approves Alexander disease drug
Health

FDA approves first drug to treat Alexander disease, offering a targeted therapy for the ultra-rare, progressive neurodegenerative disorder in children

September 13, 2026 Evan Vega
FDA Approves Pirtobrutinib Treatment
Health

FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

October 4, 2026 Evan Vega

The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.

HHS Expands Mental Health
Health

HHS Awards Nearly $250 Million to Expand Mental Health and Addiction Treatment Services

October 4, 2026 Evan Vega
Ebola Worker Evacuated Congo
Health

Doctors Without Borders Worker Evacuated After Contracting Ebola in Democratic Republic of Congo Outbreak

October 3, 2026 Evan Vega
FDA authorizes screwworm drugs
Health

FDA issues emergency use authorization for drugs to prevent and treat New World screwworm in dogs and cats

September 16, 2026 Evan Vega
FDA Approves Pirtobrutinib Treatment
Health

FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

October 4, 2026 Evan Vega

The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.

HHS Expands Mental Health
Health

HHS Awards Nearly $250 Million to Expand Mental Health and Addiction Treatment Services

October 4, 2026 Evan Vega
Ebola Worker Evacuated Congo
Health

Doctors Without Borders Worker Evacuated After Contracting Ebola in Democratic Republic of Congo Outbreak

October 3, 2026 Evan Vega
FDA authorizes screwworm drugs
Health

FDA issues emergency use authorization for drugs to prevent and treat New World screwworm in dogs and cats

September 16, 2026 Evan Vega
FDA approves Alexander disease drug
Health

FDA approves first drug to treat Alexander disease, offering a targeted therapy for the ultra-rare, progressive neurodegenerative disorder in children

September 13, 2026 Evan Vega
FDA Approves Pirtobrutinib Treatment
Health

FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

October 4, 2026 Evan Vega

The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.

HHS Expands Mental Health
Health

HHS Awards Nearly $250 Million to Expand Mental Health and Addiction Treatment Services

October 4, 2026 Evan Vega
Ebola Worker Evacuated Congo
Health

Doctors Without Borders Worker Evacuated After Contracting Ebola in Democratic Republic of Congo Outbreak

October 3, 2026 Evan Vega
FDA authorizes screwworm drugs
Health

FDA issues emergency use authorization for drugs to prevent and treat New World screwworm in dogs and cats

September 16, 2026 Evan Vega
FDA Approves Pirtobrutinib Treatment
Health

FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

October 4, 2026 Evan Vega

The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.

HHS Expands Mental Health
Health

HHS Awards Nearly $250 Million to Expand Mental Health and Addiction Treatment Services

October 4, 2026 Evan Vega
Ebola Worker Evacuated Congo
Health

Doctors Without Borders Worker Evacuated After Contracting Ebola in Democratic Republic of Congo Outbreak

October 3, 2026 Evan Vega
FDA authorizes screwworm drugs
Health

FDA issues emergency use authorization for drugs to prevent and treat New World screwworm in dogs and cats

September 16, 2026 Evan Vega
FDA approves Alexander disease drug
Health

FDA approves first drug to treat Alexander disease, offering a targeted therapy for the ultra-rare, progressive neurodegenerative disorder in children

September 13, 2026 Evan Vega
FDA HHS policy debates
Health
May 14, 2026 Evan Vega

Health-system and regulatory watchers brace for new FDA and HHS actions as mifepristone, vaccines, and psychedelic medicine dominate policy debate

Federal health officials prepare new FDA and HHS actions in 2024 amid debates on mifepristone, vaccines, and psychedelic medicine policies.

Read More
Tenerife hantavirus public health
Health
May 14, 2026 Evan Vega

Tenerife grapples with hantavirus response as WHO issues follow-up guidance amid local public health monitoring

Tenerife monitors public health after hantavirus outbreak on MV Hondius, with WHO issuing follow-up guidance amid three confirmed deaths.

Read More
GLP-1 drugs reduce breast cancer
Health
May 13, 2026 Evan Vega

Retrospective study links GLP-1 drugs to lower breast cancer mortality and recurrence, but experts question data quality

A 2026 retrospective study linked GLP-1 receptor agonists to reduced breast cancer mortality and recurrence in over 800,000 U.S. women, amid data quality concerns.

Read More
Cruise-linked hantavirus outbreak
Health
May 13, 2026 Evan Vega

Global health officials race to contain multi-country hantavirus spread after deadly cruise-linked outbreak kills three, including Dutch couple

A hantavirus outbreak linked to the MV Hondius cruise ship killed three, including a Dutch couple, prompting global health containment efforts.

Read More
Aggressive Breast Cancer Immunosuppression
Health
May 12, 2026 Evan Vega

Aggressive Breast Cancer Found to Suppress Immune Response Through Newly Identified Mechanism

Researchers discovered that the HORMAD1 gene suppresses immune response in triple-negative breast cancer by promoting PD-L1 overexpression.

Read More
Hantavirus Cruise Ship Quarantine
Health
May 12, 2026 Evan Vega

Hantavirus Outbreak on Cruise Ship Prompts 42-Day Quarantine for 18 Americans in Omaha and Atlanta Facilities

Eighteen Americans quarantined for 42 days in Omaha and Atlanta after Andes hantavirus outbreak on Dutch cruise ship MV Hondius caused three deaths.

Read More
US Cruise Health Chief Resigns
Health
May 10, 2026 Evan Vega

Top US Official Overseeing Cruise Ship Public Health Policy Steps Down Following Internal CDC Announcement

Luis Rodríguez retired as chief of the CDC’s Vessel Sanitation Program amid a hantavirus outbreak and recent staff cuts, the agency announced.

Read More
Monocyte Aging Depression Biomarker
Health
May 10, 2026 Evan Vega

Monocyte Aging Blood Test Shows Promise for Early Depression Detection in New Biomarker Study

A study of 440 women links accelerated monocyte aging to non-somatic depression symptoms, suggesting a potential early biomarker for mood-related depression.

Read More
Physicians Lawsuit Risk Increase
Health
May 10, 2026 Evan Vega

AMA Research Reveals 1 in 3 Physicians Face Lawsuit Risk, Driving Up Insurance Premiums Nationwide

A 2024 AMA report shows nearly one in three U.S. physicians face malpractice lawsuits, raising medical liability insurance premiums nationwide.

Read More
FDA reevaluates Ebvallo drug
Health
May 8, 2026 Evan Vega

FDA To Reconsider Rare Cancer Drug Ebvallo After Surprise Rejection

The FDA will reconsider Atara Biotherapeutics’ rare cancer drug Ebvallo after initially rejecting it due to manufacturing concerns.

Read More
  • ← Previous
  • Next →
Copyright © 2026 DAILYZ HEALTH NEWS. Powered by ColorMag and WordPress.